Collaborations Overview

We are committed to creating microRNA (miRNA)-targeting therapies to improve the lives of patients in need. We believe that building strategic relationships is essential to achieving that mission.

At miRagen we recognize the importance of creating strategic relationships within the biotech and pharmaceutical industries and with academic institutions globally. This collaborative approach is making important contributions in our efforts to create miRNA-targeting therapies.

Together with miRagen’s in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development, these relationships uniquely position the company to evaluate and advance best-in-class technologies and high-potential drug candidates.

For more information on business development opportunities, please contact us at